Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.59 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.59 |
| ▸ | NPC1 | O15118 | 6/20 | 0.56 |
| ▸ | RAB9A | P51151 | 6/20 | 0.56 |
| ▸ | TP53 | P04637 | 5/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.56 |
| ▸ | LMNA | P02545 | 5/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.56 |
| ▸ | GOT1 | P17174 | 2/20 | 0.56 |
| ▸ | PKM | P14618 | 2/20 | 0.56 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.56 |
| ▸ | MPO | P05164 | 1/20 | 0.56 |
| ▸ | MAOA | P21397 | 1/20 | 0.56 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.56 |
| ▸ | THPO | P40225 | 1/20 | 0.56 |
| ▸ | AOX1 | Q06278 | 1/20 | 0.56 |
| ▸ | ACOX1 | Q15067 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 2/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29674926 | 1.00 | ALDH1A1 (0.59) | ALDH1A1CYP1A2CYP2C19NPC1RAB9A | |
| SCHEMBL9461493 | 0.83 | LMNA (0.56) | ALDH1A1CYP1A2NPC1RAB9ATP53 | |
| SCHEMBL599375 | 0.82 | LMNA (0.51) | ALDH1A1CYP1A2NPC1RAB9ATP53 | |
| SCHEMBL8808680 | 0.79 | LMNA (0.52) | ALDH1A1CYP1A2NPC1RAB9ATP53 | |
| SCHEMBL21965729 | 0.79 | LMNA (0.43) | ALDH1A1CYP1A2NPC1RAB9ATP53 | |
| Formaldehyde SCHEMBL23529395 | 0.78 | LMNA (0.52) | ALDH1A1CYP1A2NPC1RAB9ATP53 | |
| Hydrochloric Acid SCHEMBL2488955 | 0.78 | LMNA (0.51) | ALDH1A1CYP1A2NPC1RAB9ATP53 | |
| Sulfur Dioxide SCHEMBL27498686 | 0.77 | LMNA (0.51) | ALDH1A1CYP1A2NPC1RAB9ATP53 | |
| SCHEMBL8809522 | 0.77 | RAB9A (0.58) | ALDH1A1CYP1A2NPC1RAB9ATP53 | |
| SCHEMBL7630666 | 0.77 | LMNA (0.50) | ALDH1A1CYP1A2NPC1RAB9ATP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12429483-B2 | System and method for determining onset and disease progression | RESPIRATION SCAN LTD (IL) | 2025-09-30 | — | — | US | claimed |
| EP-0539805-B1 | Phthalazines substituted on position 1 by an ether group and process for their preparation | ASTA MEDICA AG (DE) | 1997-09-03 | — | — | EP | claimed |
| US-5354750-A | Analgesics, antinflammatory, anticonvulsive and antipyretic agents | ASTA MEDICA AKTIENGESELLSCHAFT (DE) | 1994-10-11 | — | — | US | claimed |
| EP-0539805-A1 | Phthalazines substituted on position 1 by an ether or a thioether group and process for their preparation | ASTA Medica Aktiengesellschaft (DE) | 1993-05-05 | — | — | EP | claimed |
| JP-5222002-A | — | — | None | — | — | JP | disclosed |
| US-12429483-B2 | System and method for determining onset and disease progression | RESPIRATION SCAN LTD (IL) | 2025-09-30 | — | — | US | disclosed |
| EP-4164481-B1 | A DEVICE FOR MEASURING VOLATILE MARKERS IN BREATH | NANOSE MEDICAL LTD (IL) | 2024-10-16 | — | — | EP | disclosed |
| US-20230337934-A1 | A DEVICE FOR MEASURING VOLATILE MARKERS IN BREATH | NANOSE MEDICAL LTD (IL) | 2023-10-26 | — | — | US | disclosed |
| EP-4164481-A1 | A DEVICE FOR MEASURING VOLATILE MARKERS IN BREATH | Nanose Medical Ltd (IL) | 2023-04-19 | — | — | EP | disclosed |
| US-20220317122-A1 | SYSTEM AND METHOD FOR DETERMINING ONSET AND DISEASE PROGRESSION | RESPIRATION SCAN LTD. (IL) | 2022-10-06 | — | — | US | disclosed |
| EP-4013302-A1 | SYSTEM AND METHOD FOR DETERMINING ONSET AND DISEASE PROGRESSION | Respiration Scan Ltd (IL) | 2022-06-22 | — | — | EP | disclosed |
| WO-2021250674-A1 | A DEVICE FOR MEASURING VOLATILE MARKERS IN BREATH | NANOSE MEDICAL LTD (IL) | 2021-12-16 | — | — | WO | disclosed |
| WO-2011115603-A1 | ANTI-CORROSION AGENTS FOR TRANSPARENT CONDUCTIVE FILM | CARESTREAM HEALTH, INC. (US) | 2011-09-22 | — | — | WO | disclosed |
| US-20110065704-A1 | COMPOUNDS FOR MODULATING RNA BINDING PROTEINS AND USES THEREFOR | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2011-03-17 | — | — | US | disclosed |
| US-20110065704-A1 | COMPOUNDS FOR MODULATING RNA BINDING PROTEINS AND USES THEREFOR | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2011-03-17 | — | — | US | disclosed |
| WO-2010151797-A2 | COMPOUNDS FOR MODULATING RNA BINDING PROTEINS AND USES THEREFOR | UNIVERSITY OF MASSACHUSETTS (US) | 2010-12-29 | — | — | WO | disclosed |
| EP-0539805-B1 | Phthalazines substituted on position 1 by an ether group and process for their preparation | ASTA MEDICA AG (DE) | 1997-09-03 | — | — | EP | disclosed |
| US-5354750-A | Analgesics, antinflammatory, anticonvulsive and antipyretic agents | ASTA MEDICA AKTIENGESELLSCHAFT (DE) | 1994-10-11 | — | — | US | disclosed |
| JP-H05222002-A | PHTHALAZINE CONTAINING ETHER OR THIOETHER GROUP IN 1-POSITION, ITS PREPARATION AND PHARMACEUTICAL CONTAINING THE SAME, WHICH HAS ANALGESIC, ANTI-INFLAMMATORY, ANTICONVULSIVE AND ANTI-PYRETIC ACTION, AND THEIR PREPARATION | ASTA MEDICA AG | 1993-08-31 | — | — | JP | disclosed |
| EP-0539805-A1 | Phthalazines substituted on position 1 by an ether or a thioether group and process for their preparation | ASTA Medica Aktiengesellschaft (DE) | 1993-05-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110065704-A1 | COMPOUNDS FOR MODULATING RNA BINDING PROTEINS AND USES THEREFOR | TIA1, ZFP3, RBM3 | ALDH1A1 3135/4885CYP1A2 4801/4885CYP2C19 4876/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.